Optimind Pharma – Debenture Conversion
TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the “Optimind” or the “Company”) advises that it has reached agreement with holders of principal amount $303,750 convertible debentures maturing on Janu…